These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 17034025)
1. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature. Robertson MD; Zumberg M Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025 [TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma. Marques MB; Mayfield CA; Blackall DP Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154 [TBL] [Abstract][Full Text] [Related]
3. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Furlan M Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284 [TBL] [Abstract][Full Text] [Related]
4. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Furlan M; Robles R; Solenthaler M; Lämmle B Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594 [TBL] [Abstract][Full Text] [Related]
5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
6. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904 [TBL] [Abstract][Full Text] [Related]
7. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Kremer Hovinga JA; Studt JD; Lämmle B Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254 [TBL] [Abstract][Full Text] [Related]
8. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811 [TBL] [Abstract][Full Text] [Related]
9. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura. Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376 [TBL] [Abstract][Full Text] [Related]
11. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura. Rock G; Clark WF; Anderson D; Benny B; Sutton D; Leblond P; Sternbach M; Sontrop J; Thromb Res; 2013 Apr; 131(4):308-12. PubMed ID: 23411128 [TBL] [Abstract][Full Text] [Related]